A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01772316 · COMPLETED
Trial details
- NCT number
- NCT01772316
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.